Immunotherapy trial for rectal cancer offers hope for future

A small immunotherapy trial for a certain type of rectal cancer reports a 100% success rate. Dr. Jon LaPook explains how it's designed to work, and how it could be used as a model to treat other cancers.

#health #cancertreatment #cancer

Each weekday morning, "CBS Mornings” co-hosts Gayle King, Tony Dokoupil and Nate Burleson bring you the latest breaking news, smart conversation and in-depth feature reporting. "CBS Mornings" airs weekdays at 7 a.m. on CBS and stream it at 8 a.m. ET on the CBS News app.

Subscribe to “CBS Mornings” on YouTube:    / cbsmornings  
Watch CBS News: http://cbsn.ws/1PlLpZ7c
Download the CBS News app: http://cbsn.ws/1Xb1WC8
Follow "CBS Mornings" on Instagram: https://bit.ly/3A13OqA
Like "CBS Mornings" on Facebook: https://bit.ly/3tpOx00
Follow "CBS Mornings" on Twitter: https://bit.ly/38QQp8B
Subscribe to our newsletter: http://cbsn.ws/1RqHw7T​
Try Paramount+ free: https://bit.ly/2OiW1kZ

For video licensing inquiries, contact: [email protected]